The AI-designed proteins could form the basis of a new generation of therapies for snakebites — which kill an estimated 100,000 people each year and are still treated much as they were a century ago.

The current way to produce antivenoms is antiquated. Experiments in mice suggest that an artificial intelligence approach could save time and money.